The Biden Administration has asked a federal appeals court to reconsider a Texas judge’s ruling that voided a Department of [...] Read More »
Month: October 2024
Pfizer’s top executive told investors this week that the 340B program “is one of the biggest issues,” during an earnings [...] Read More »
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...] Read More »
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Drugmakers Xellia Pharmaceuticals and Ascend Laboratories will refund 340B providers for some products following ceiling price recalculations, according to notices [...] Read More »
Please Login or Become a Paid Subscriber to View this Content
If you are already a
After a long period in which many 340B providers felt helpless, the last month has brought two major wins. First, [...] Read More »
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Q: Where did you grow up?
Pleasanton, CA
Q: Where did you go to college/graduate school?
University of California Davis
Q: What are your favorites?
Food: I love to cook so it’s hard to pick one thing. My kids’ favorite home cooked meal is my Italian risotto recipe.
Movie: Read More »
Kalderos, the drug industry vendor behind two 340B claims data submission platforms which support 340B rebates, will file an updated [...] Read More »
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A high-profile former Vermont governor with reported drug industry ties took aim at hospitals’ use of 340B savings, calling for [...] Read More »
Please Login or Become a Paid Subscriber to View this Content
If you are already a
AstraZeneca will discontinue a certain bottle dosage of its breast cancer drug Truqap (capiversatib) by the end of the year, [...] Read More »
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Belgium pharmaceutical giant UCB is extending its 340B contract pharmacy restrictions to all federal grantees and adding new data submission [...] Read More »